New York
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
Nigerian nationals in US now to be evacuated Saturday
Luc Doan/Foursquare The federal government has announced that the evacuation of the first batch of Nigerians from the United States will take place on Saturday, May 9, as against Sunday, May 10, 2020 that was earlier announced. It added that the Ethiopian Airline aircraft would depart Newark Liberty International Airport, New Jersey, on May 9, 2020 at the estimated time of 19:15 hours and arrive at the Nnamdi Azikiwe Airport, Abuja on May 10, 2020, at the estimated time of 11:15 hours. The Consulate General of Nigeria in New York in a statement dated May 5, 2020, and made available to journalists on Thursday, added that only 270 passengers would be accommodated in the evacuation batch. It stated categorically that the mission would attend to applicants on a first come, first served basis a...
